Efficacy and Safety of Daratumumab-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma – A Systematic Literature Review and Network Meta-analysis — Meletios A Dimopoulos (2017) | RDL Network
Efficacy and Safety of Daratumumab-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma – A Systematic Literature Review and Network Meta-analysis
Thierry Façon, Rubén Niesvizky, María‐Victoria Mateos, David S. Siegel, Cara A. Rosenbaum, Sara Bringhen, Katja Weisel, P. Joy Ho, Heinz Ludwig, Shaji Kumar, Kenneth T. Wang, Mihaela Obreja, Zhao Yang, Zandra Klippel, Khalid Mezzi, Amanda Goldrick, Christina Tekle, Meletios A Dimopoulos
Meletios A Dimopoulos, Jonathan L. Kaufman, Darrell White, Gordon Cook, Maria Teresa Rizzo, Yingxin Xu, Kyle Fahrbach, Maren Gaudig, Mary Slavcev, Lindsay Dearden, Annette Lam
Thierry Façon, Jesús F. San Miguel, Meletios A Dimopoulos, María‐Victoria Mateos, Michèle Cavo, S. van Beekhuizen, Zijiao Yuan, João Mendes, Annette Lam, Jianming He, Eric M. Ammann, Shaji Kumar
María‐Victoria Mateos, Andrew Spencer, Ajay K. Nooka, Luděk Pour, Katja Weisel, Michèle Cavo, Jacob P. Laubach, Gordon Cook, Shinsuke Iida, Lotfi Benboubker, Saad Z. Usmani, Sung‐Soo Yoon, Nizar J. Bahlis, Christopher Chiu, Jordan M. Schecter, Kaida Wu, Xiang Qin, David Soong, Meletios A Dimopoulos
Kristine A. Frerichs, Christie P.M. Verkleij, Meletios A Dimopoulos, Jhon A. Marin Soto, Sonja Zweegman, Mary H. Young, Kathryn J. Newhall, Tuna Mutis, Niels W.C.J. van de Donk
Discussion(0)
No comments yet. Be the first to comment.